Vontobel Holding’s Novo Nordisk NVO Stock Holding History

Vontobel Holding’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.7M	Buy	290,222 +114,071	+65%	+$5.4M	0.04%	262
2025 Q4	$8.96M	Buy	176,151 +48,733	+38%	+$2.49M	0.03%	304
2025 Q3	$7.07M	Sell	127,418 -13,325	-9%	-$780K	0.02%	311
2025 Q2	$9.71M	Sell	140,743 -69,642	-33%	-$4.74M	0.03%	260
2025 Q1	$14.6M	Sell	210,385 -52,817	-20%	-$4.36M	0.05%	190
2024 Q4	$22.6M	Buy	263,202 +251,064	+2,068%	+$27.1M	0.08%	152
2024 Q3	$1.45M	Buy	12,138 +2,295	+23%	+$306K	﹤0.01%	518
2024 Q2	$1.4M	Buy	+9,843	New	+$1.3M	﹤0.01%	505
2023 Q3	–	Sell	-3,996	Closed	-$323K	–	1114
2023 Q2	$323K	Buy	+3,996	New	+$326K	﹤0.01%	903
2022 Q4	–	Sell	-5,434	Closed	-$271K	–	1111
2022 Q3	$271K	Buy	5,434 +238	+5%	+$12.8K	﹤0.01%	880
2022 Q2	$289K	Buy	+5,196	New	+$288K	﹤0.01%	853

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Vontobel Holding's NVO Position: Q1 2026 in Review

Vontobel Holding increased its Novo Nordisk (NVO) stake by 65% in Q1 2026, buying an estimated $5.4M and bringing the position to 290,222 shares worth $10.7M. The position accounts for 0.04% of the portfolio, ranked #262.

Vontobel Holding first reported a position in NVO in Q2 2022 and has held it in 11 quarters since. The position peaked at $22.6M in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Vontobel Holding held 290,222 shares of Novo Nordisk worth $10.7M as of Q1 2026.
Vontobel Holding bought 114,071 Novo Nordisk shares in Q1 2026, an estimated $5.4M.
Novo Nordisk made up 0.04% of Vontobel Holding's portfolio in Q1 2026, its #262 holding.
Vontobel Holding first reported a position in Novo Nordisk in Q2 2022 and has held it in 11 quarters since.
Vontobel Holding's Novo Nordisk position peaked at $22.6M in Q4 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.